OXFORD ASSET MANAGEMENT LLP - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2020$28,252,000
+14.7%
261,761
+23.7%
3.98%
+482.6%
Q4 2019$24,631,000
+199.6%
211,646
+194.7%
0.68%
+244.9%
Q3 2019$8,221,000
+363.7%
71,815
+220.3%
0.20%
+421.1%
Q4 2017$1,773,000
-0.1%
22,419
+15.4%
0.04%
+11.8%
Q3 2017$1,774,00019,4250.03%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2020
NameSharesValueWeighting ↓
NEW SILK ROAD INVESTMENT PTE LTD 189,395$17,476,0009.13%
VERNIER CAPITAL PARTNERS, LP 122,600$11,312,0008.31%
RUDMAN ERROL M 26,901$2,482,0001.42%
HERMES INVESTMENT MANAGEMENT LTD 712,424$65,735,0000.99%
Hillhouse Capital Management 618,391$57,059,0000.94%
COMGEST GLOBAL INVESTORS S.A.S. 356,252$32,872,0000.76%
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 363,190$33,511,0000.26%
FIL Ltd 914,848$84,413,0000.24%
Gideon Capital Advisors, Inc. 2,494$230,0000.23%
WASATCH ADVISORS LP 137,482$12,685,0000.17%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders